MAGEA9 Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIPA5103303-Each-of-1 | In Stock | ₹ 41,607.50 |
PIPA5103303 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 41,607.50
GST (18%): ₹ 7,489.35
Total Price: ₹ 49,096.85
Antigen
MAGEA9
Classification
Polyclonal
Conjugate
Unconjugated
Gene
MAGEA9
Gene Alias
Cancer/testis antigen 1.9; cancer/testis antigen family 1, member 9; CT1.9; MAGE family member A9; MAGE9; MAGE-9 antigen; MAGEA9; MAGEA9A; MAGEA9B; melanoma antigen family A, 9; melanoma antigen family A9; melanoma-associated antigen 9; MGC114427; similar to melanoma antigen family A, 5; uncharacterized protein LOC317297
Host Species
Rabbit
Purification Method
Affinity chromatography
Regulatory Status
RUO
Gene ID (Entrez)
4108
Content And Storage
-20°C
Form
Liquid
Applications
Western Blot
Concentration
1 mg/mL
Formulation
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
Gene Accession No.
P43362
Gene Symbols
MAGEA9
Immunogen
A synthesized peptide derived from human MAGEA9, MAGEA9B(Accession P43362), corresponding to amino acid residues M1-S41.
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human
Product Type
Antibody
Isotype
IgG
Related Products
Description
- Antibody detects endogenous levels of total MAGEA9
- MAGEA9 is a member of the MAGEA gene family
- The members of this family have their entire coding sequences located in the last exon, and the encoded proteins show 50 to 80% sequence identity between each other
- The promoters and first exons of the MAGEA genes show considerable variability, suggesting that the existence of this gene family enables the same function to be expressed under different transcriptional controls
- The MAGEA genes are expressed at a high level in a number of tumors of various histologic types, and are silent in normal tissues with the exception of testis and placenta
- The MAGEA genes are clustered on chromosome Xq28
- They may be implicated in some hereditary disorders, such as dyskeratosis congenita.